These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 17175811)
1. Rat modeling for GABA defects in schizophrenia. Benes FM; Gisabella B Adv Pharmacol; 2006; 54():73-93. PubMed ID: 17175811 [No Abstract] [Full Text] [Related]
2. [Significance of GABA in pain syndrome pathogenes]. Kukushkin LN; Igonkina SI Patol Fiziol Eksp Ter; 2014; (1):68-78. PubMed ID: 25051687 [TBL] [Abstract][Full Text] [Related]
3. Schizophrenia: The making of a troubled mind. Dobbs D Nature; 2010 Nov; 468(7321):154-6. PubMed ID: 21068803 [No Abstract] [Full Text] [Related]
4. Synaptic dysfunction in schizophrenia. Yin DM; Chen YJ; Sathyamurthy A; Xiong WC; Mei L Adv Exp Med Biol; 2012; 970():493-516. PubMed ID: 22351070 [TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of [11C]methoxy-norchloroprogabidic acid, a potential PET tracer for GABA receptors in the brain. Santens P; De Vos F; Bouden D; Slegers G; Lemahieu I; Boon P; De Reuck J Nucl Med Biol; 1999 Apr; 26(3):323-5. PubMed ID: 10363804 [No Abstract] [Full Text] [Related]
6. Agonist responses of (R)- and (S)-3-fluoro-γ-aminobutyric acids suggest an enantiomeric fold for GABA binding to GABA(C) receptors. Yamamoto I; Deniau GP; Gavande N; Chebib M; Johnston GA; O'Hagan D Chem Commun (Camb); 2011 Jul; 47(28):7956-8. PubMed ID: 21670807 [TBL] [Abstract][Full Text] [Related]
7. GABAergic drugs and Alzheimer's disease. Limon A; Reyes-Ruiz JM; Miledi R Future Med Chem; 2011 Feb; 3(2):149-53. PubMed ID: 21428809 [No Abstract] [Full Text] [Related]
8. GABA and schizophrenia: Where we stand and where we need to go. Glausier JR; Lewis DA Schizophr Res; 2017 Mar; 181():2-3. PubMed ID: 28179064 [No Abstract] [Full Text] [Related]
9. Activation of inhibitory pathways suppresses the induction of long-term potentiation in neurons of the rat lateral septal nucleus. Hasuo H; Akasu T Neuroscience; 2001; 105(2):343-52. PubMed ID: 11672602 [TBL] [Abstract][Full Text] [Related]
10. Critical review of GABA-ergic drugs in the treatment of schizophrenia. Wassef AA; Dott SG; Harris A; Brown A; O'Boyle M; Meyer WJ; Rose RM J Clin Psychopharmacol; 1999 Jun; 19(3):222-32. PubMed ID: 10350028 [TBL] [Abstract][Full Text] [Related]
11. gamma-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia. Van Kammen DP Am J Psychiatry; 1977 Feb; 134(2):138-43. PubMed ID: 835733 [TBL] [Abstract][Full Text] [Related]
12. GABA and brain abnormalities in schizophrenia. van Kammen DP; Petty F; Kelley ME; Kramer GL; Barry EJ; Yao JK; Gurklis JA; Peters JL Psychiatry Res; 1998 Apr; 82(1):25-35. PubMed ID: 9645548 [TBL] [Abstract][Full Text] [Related]
13. The GABA system in schizophrenia: cells, molecules and microcircuitry. Benes FM Schizophr Res; 2015 Sep; 167(1-3):1-3. PubMed ID: 26255083 [TBL] [Abstract][Full Text] [Related]
14. [Participation of central H-cholinoreceptors in preventing respiration damping upon activation of the GABA-ergic system of the brain]. Sliuta AD; Tarakanov IA; Safonov VA Biull Eksp Biol Med; 1995 Jan; 119(1):17-20. PubMed ID: 7718794 [No Abstract] [Full Text] [Related]
15. Effects of chronic ethanol exposure on GABA receptors and GABAB receptor modulation of 3H-GABA release in the hippocampus. Peris J; Eppler B; Hu M; Walker DW; Hunter BE; Mason K; Anderson KJ Alcohol Clin Exp Res; 1997 Sep; 21(6):1047-52. PubMed ID: 9309316 [TBL] [Abstract][Full Text] [Related]
16. Amygdalar activation alters the hippocampal GABA system: "partial" modelling for postmortem changes in schizophrenia. Berretta S; Munno DW; Benes FM J Comp Neurol; 2001 Mar; 431(2):129-38. PubMed ID: 11169995 [TBL] [Abstract][Full Text] [Related]
17. GHB and GABA. Plantey F Am J Psychiatry; 1977 Sep; 134(9):1045-6. PubMed ID: 900292 [No Abstract] [Full Text] [Related]